Liquid Biopsies in Follicular Thyroid Carcinomas-A Brief Report
- PMID: 39061714
- PMCID: PMC11276045
- DOI: 10.3390/diagnostics14141577
Liquid Biopsies in Follicular Thyroid Carcinomas-A Brief Report
Abstract
Thyroid cancer (TC) represents a significant health burden globally, with follicular thyroid cancer (FTC) posing diagnostic challenges despite advancements. This pilot study aimed to evaluate the utility of a liquid biopsy with cell-free DNA (cfDNA) in patients with FTC. Blood samples were collected from 13 patients diagnosed with FTC, DNA extraction was performed, and cfDNA was analyzed using the Illumina's TruSight Oncology 500 High-Throughput panel. The results revealed low tumor mutational burden and minimal pathogenic variants in cfDNA, indicating challenges such as low DNA yield and poor material quality despite adequate coverage. Our findings indicate that cfDNA as an add-on diagnostic tool in patients with FTC might not be a useful supplement.
Keywords: cell-free DNA; follicular thyroid cancer; liquid biopsies.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
- 
    - Mirian C., Grønhøj C., Jensen D.H., Jakobsen K.K., Karnov K., Jensen J.S., Hahn C.H., Klitmøller T.A., Bentzen J., von Buchwald C. Trends in thyroid cancer: Retrospective analysis of incidence and survival in Denmark 1980–2014. Cancer Epidemiol. 2018;55:81–87. doi: 10.1016/j.canep.2018.05.009. - DOI - PubMed
 
- 
    - Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F., Bsc M.F.B., Me J.F., Soerjomataram M.I., et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
 
Grants and funding
LinkOut - more resources
- Full Text Sources
 
         
               
              